<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Drug Alcohol Depend</journal-id><journal-id journal-id-type="iso-abbrev">Drug Alcohol Depend</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Drug and alcohol dependence</journal-title></journal-title-group><issn pub-type="ppub">0376-8716</issn><issn pub-type="epub">1879-0046</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11088491</article-id><article-id pub-id-type="pmcid-ver">PMC11088491.319</article-id><article-id pub-id-type="pmcaid">11088491</article-id><article-id pub-id-type="pmcaiid">11088491</article-id><article-id pub-id-type="manuscript-id">NIHMS1985767</article-id><article-id pub-id-type="pmid">38581920</article-id><article-id pub-id-type="doi">10.1016/j.drugalcdep.2024.111283</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1985767</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1985767</article-id><article-version article-version-type="pmc-version">319</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Methadone dosing at New York State opioid treatment programs following initial revisions to federal regulations</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Jordan</surname><given-names initials="AE">Ashly E.</given-names></name><xref rid="A1" ref-type="aff">a</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bachhuber</surname><given-names initials="MA">Marcus A.</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tuazon</surname><given-names initials="E">Ellenie</given-names></name><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jimenez</surname><given-names initials="C">Christian</given-names></name><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lincourt</surname><given-names initials="P">Pat</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hussain</surname><given-names initials="S">Shazia</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rubinfeld</surname><given-names initials="J">Jason</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cunningham</surname><given-names initials="CO">Chinazo O.</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib></contrib-group><aff id="A1"><label>a</label>New York State Office of Addiction Services and Supports, Albany, NY, USA</aff><aff id="A2"><label>b</label>New York City Department of Health and Mental Hygiene, Queens, NY, USA</aff><author-notes><corresp id="CR1"><label>*</label>Correspondence to: Director of Research and Program Evaluation, New York State Office of Addiction Services and Supports, 501 7th Avenue, Floor 8, New York NY, 10018, USA. <email>Ashly.Jordan@oasas.ny.gov</email> (A.E. Jordan).</corresp><fn fn-type="COI-statement" id="FN2"><p id="P25">Declaration of Competing Interest</p><p id="P26">None</p></fn></author-notes><pub-date pub-type="ppub"><day>01</day><month>5</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>03</day><month>4</month><year>2024</year></pub-date><volume>258</volume><issue-id pub-id-type="pmc-issue-id">462230</issue-id><fpage>111283</fpage><lpage>111283</lpage><pub-history><event event-type="nihms-submitted"><date><day>13</day><month>04</month><year>2024</year></date></event><event event-type="pmc-release"><date><day>01</day><month>05</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>01</day><month>05</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-05-01 00:25:14.317"><day>01</day><month>05</month><year>2025</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1985767.pdf"/><abstract id="ABS1"><sec id="S1"><title>Introduction:</title><p id="P1">In March 2020, a temporary federal regulatory exemption for opioid treatment programs (OTPs) was issued, allowing for a greater number of take-home methadone doses than was previously permitted. In the same month, to address financial sustainability, New York State (NYS) Medicaid also transitioned to a bundle reimbursement methodology for OTPs. We examined methadone dosing schedules in NYS before and after these regulatory and financing changes.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">We conducted a retrospective cohort study using NYS OTP patient data from two sources: the client data system for a baseline period (February 2020) and survey data collected after regulatory and financing changes (May 2020 to August 2021, 64 weekly surveys). We compared methadone dosing schedules over time using chi-square tests and Poisson regression.</p></sec><sec id="S3"><title>Result:</title><p id="P3">At baseline, data were available for 78% (n=77/99) of OTPs including 90.9% (n=26,225/28,839) of their enrolled patients. During the survey period, 99 OTPs completed 93.1% (n=5901/6336) of weekly surveys, with a mean statewide weekly patient census of 38,904 (SD=1214.5). Between February and May 2020, daily dosing significantly decreased from 55.4% to 16.3% of patients (&#8722;39.1 percentage points [95%CI: &#8722;39.8 to &#8722;38.4]), although it significantly increased subsequently (3.33%/4-weeks [95%CI: 3.28, 3.39]). In addition, weekly-to-monthly dosing significantly increased from 26.9% to 54.5% of patients (27.6 percentage points [95%CI: 26.9, 28.4]), although it significantly decreased subsequently (&#8722;1.19%/4-weeks [95%CI: &#8722;1.23, &#8722;1.15]).</p></sec><sec id="S4"><title>Discussion:</title><p id="P4">Despite large initial changes, we found a trend toward gradual return to more restrictive dosing schedules. OTPs need further support in leveraging new opportunities to improve methadone treatment and outcomes.</p></sec></abstract><kwd-group><kwd>Overdose</kwd><kwd>Methadone</kwd><kwd>Opioid Use Disorder</kwd><kwd>Health policy</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>